Agents in development for type 2 diabetes.

被引：1
|
作者：
Jarvis B. [1 ]
Elkinson S. [1 ]
机构：
[1] Adis International, Auckland
来源：
Drugs in R & D | 1999年 / 2卷 / 2期
关键词：
Adis International Limited; Ornithine; Acarbose; Insulin Glargine; Troglitazone;
D O I：
10.2165/00126839-199902020-00002
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：95 / 99
页数：4
相关论文
共 50 条
  • [1] Nephropathy in type 2 diabetes.
    Vandor, T
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06): : 441 - 441
  • [2] Role of inflammatory pathways in the development and cardiovascular complications of type 2 diabetes.
    Huerta M.G.
    Nadler J.L.
    Current Diabetes Reports, 2002, 2 (5) : 396 - 402
  • [3] Mortality in people with Type 2 diabetes.
    Lawrenson, R
    Mulnier, H
    Raleigh, V
    DIABETOLOGIA, 2003, 46 : A77 - A77
  • [4] Insulin therapy in type 2 diabetes.
    Ametov, A
    Topchiashvili, V
    DIABETOLOGIA, 1997, 40 : 1685 - 1685
  • [5] Nephropathy in patients with type 2 diabetes.
    Remuzzi, G
    Schieppati, A
    Ruggenenti, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15): : 1145 - 1151
  • [6] Arterial hypertension and type 2 diabetes.
    Louda, F.
    Addi, H.
    Hallab, L.
    Chadli, A.
    Elghomari, H.
    Farouqi, A.
    DIABETES & METABOLISM, 2010, 36 : A53 - A54
  • [7] Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes.
    Lyssenko, Valeriya
    Jonsson, Anna
    Almgren, Peter
    Pulizzi, Nicolo
    Isomaa, Bo
    Tuomi, Tiinamaija
    Berglund, Goran
    Altshuler, David
    Nilsson, Peter
    Groop, Leif
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21): : 2220 - 2232
  • [8] Cardiovascular fitness and type 2 diabetes.
    Mullooly C.
    Current Diabetes Reports, 2002, 2 (5) : 441 - 447
  • [9] Protein diet in type 2 diabetes. No
    Pelaz-Berdullas, Laura
    Luis Calle-Pascual, Alfonso
    AVANCES EN DIABETOLOGIA, 2012, 28 (01): : 27 - 31
  • [10] Glomerular ultrastructure in type 2 diabetes.
    Fioretto, P
    Mauer, M
    Barzon, I
    Dalla Vestra, M
    Bortoloso, E
    Saller, A
    Nosadini, R
    Crepaldi, G
    DIABETOLOGIA, 1999, 42 : A268 - A268
12345